NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,139 filers reported holding NOVARTIS A G in Q4 2021. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $299,770 | +4.8% | 2,943 | 0.0% | 0.14% | +3.7% |
| Q2 2023 | $285,938 | +5.6% | 2,943 | 0.0% | 0.14% | +0.7% |
| Q1 2023 | $270,752 | +1.4% | 2,943 | 0.0% | 0.13% | -2.9% |
| Q4 2022 | $266,954 | +16.1% | 2,943 | -2.5% | 0.14% | +5.3% |
| Q3 2022 | $230,000 | -9.8% | 3,020 | 0.0% | 0.13% | -5.8% |
| Q2 2022 | $255,000 | -5.2% | 3,020 | -1.5% | 0.14% | +7.8% |
| Q1 2022 | $269,000 | +0.4% | 3,067 | +0.0% | 0.13% | +9.3% |
| Q4 2021 | $268,000 | +7.2% | 3,066 | +0.3% | 0.12% | +4.4% |
| Q3 2021 | $250,000 | -10.1% | 3,058 | +0.4% | 0.11% | -1.7% |
| Q2 2021 | $278,000 | -3.5% | 3,045 | 0.0% | 0.12% | -18.4% |
| Q4 2020 | $288,000 | +8.7% | 3,045 | +0.1% | 0.14% | -13.0% |
| Q3 2020 | $265,000 | – | 3,043 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GODSEY & GIBB, INC | 184,900 | $15,121,000 | 6.74% |
| Martin Investment Management, LLC | 289,924 | $23,710,000 | 5.98% |
| Camber Capital Management LP | 2,000,000 | $163,560,000 | 5.04% |
| MANAGED ASSET PORTFOLIOS, LLC | 381,778 | $31,222,000 | 4.76% |
| PROFESSIONAL ADVISORY SERVICES INC | 267,779 | $21,899,000 | 3.22% |
| SCHARF INVESTMENTS, LLC | 1,244,711 | $101,794,000 | 3.21% |
| GARLAND CAPITAL MANAGEMENT INC | 50,755 | $4,151,000 | 2.97% |
| First Fiduciary Investment Counsel, Inc. | 167,378 | $13,688,000 | 2.67% |
| WILKINS INVESTMENT COUNSEL INC | 130,590 | $10,680,000 | 2.61% |
| Lowell Blake & Associates Inc. | 66,309 | $5,423,000 | 2.52% |